Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (163K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (256)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Bielinska, A
Right arrow Articles by Baker, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bielinska, A
Right arrow Articles by Baker, J., Jr
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, Vol 24, Issue 11 2176-2182, Copyright © 1996 by Oxford University Press


ARTICLES

Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers

A Bielinska, JF Kukowska-Latallo, J Johnson, DA Tomalia and JR Baker Jr
Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109-0666, USA.

Starburst polyamidoamine (PAMAM) dendrimers are a new type of synthetic polymer characterized by a branched spherical shape and a high density surface charge. We have investigated the ability of these dendrimers to function as an effective delivery system for antisense oligonucleotides and 'antisense expression plasmids' for the targeted modulation of gene expression. Dendrimers bind to various forms of nucleic acids on the basis of electrostatic interactions, and the ability of DNA-dendrimer complexes to transfer oligonucleotides and plasmid DNA to mediate antisense inhibition was assessed in an in vitro cell culture system. Cell lines that permanently express luciferase gene were developed using dendrimer mediated transfection. Transfections of antisense oligonucleotides or antisense cDNA plasmids into these cell lines using dendrimers resulted in a specific and dose dependent inhibition of luciferase expression. This inhibition caused approximately 25-50% reduction of baseline luciferase activity. Binding of the phosphodiester oligonucleotides to dendrimers also extended their intracellular survival. While dendrimers were not cytotoxic at the concentrations effective for DNA transfer, some non-specific suppression of luciferase expression was observed. Our results indicate that Starburst dendrimers can be effective carriers for the introduction of regulatory nucleic acids and facilitate the suppression of the specific gene expression.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
J. F. Kukowska-Latallo, K. A. Candido, Z. Cao, S. S. Nigavekar, I. J. Majoros, T. P. Thomas, L. P. Balogh, M. K. Khan, and J. R. Baker Jr.
Nanoparticle Targeting of Anticancer Drug Improves Therapeutic Response in Animal Model of Human Epithelial Cancer
Cancer Res., June 15, 2005; 65(12): 5317 - 5324.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
L. M. Santhakumaran, T. Thomas, and T. J. Thomas
Enhanced cellular uptake of a triplex-forming oligonucleotide by nanoparticle formation in the presence of polypropylenimine dendrimers
Nucleic Acids Res., April 15, 2004; 32(7): 2102 - 2112.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. J. Provoda, E. M. Stier, and K.-D. Lee
Tumor Cell Killing Enabled by Listeriolysin O-liposome-mediated Delivery of the Protein Toxin Gelonin
J. Biol. Chem., September 12, 2003; 278(37): 35102 - 35108.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Mamede, T. Saga, H. Kobayashi, T. Ishimori, T. Higashi, N. Sato, M. W. Brechbiel, and J. Konishi
Radiolabeling of Avidin with Very High Specific Activity for Internal Radiation Therapy of Intraperitoneally Disseminated Tumors
Clin. Cancer Res., September 1, 2003; 9(10): 3756 - 3762.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
N. Dias and C. A. Stein
Antisense Oligonucleotides: Basic Concepts and Mechanisms
Mol. Cancer Ther., March 1, 2002; 1(5): 347 - 355.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. Sato, H. Kobayashi, T. Saga, Y. Nakamoto, T. Ishimori, K. Togashi, Y. Fujibayashi, J. Konishi, and M. W. Brechbiel
Tumor Targeting and Imaging of Intraperitoneal Tumors by Use of Antisense Oligo-DNA Complexed with Dendrimers and/or Avidin in Mice
Clin. Cancer Res., November 1, 2001; 7(11): 3606 - 3612.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. J. T. GEORGE, C. V. ARANCIBIA-CARCAMO, H. M. AWAD, R. M. COMER, Z. FEHEVARI, W. J. KING, M. KADIFACHI, T. HUDDE, C. KEROUEDAN-LEBOSSE, F. MIRZA, et al.
Gene Delivery to the Corneal Endothelium
Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): S194 - 200.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
N. Bourne, L. R. Stanberry, E. R. Kern, G. Holan, B. Matthews, and D. I. Bernstein
Dendrimers, a New Class of Candidate Topical Microbicides with Activity against Herpes Simplex Virus Infection
Antimicrob. Agents Chemother., September 1, 2000; 44(9): 2471 - 2474.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
G. Schmajuk, H. Sierakowska, and R. Kole
Antisense Oligonucleotides with Different Backbones. MODIFICATION OF SPLICING PATHWAYS AND EFFICACY OF UPTAKE
J. Biol. Chem., July 30, 1999; 274(31): 21783 - 21789.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. K. Alahari, R. DeLong, M. H. Fisher, N. M. Dean, P. Viliet, and R. L. Juliano
Novel Chemically Modified Oligonucleotides Provide Potent Inhibition of P-Glycoprotein Expression
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 419 - 428.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.